DSS, Inc. (DSS)
NYSEAMERICAN: DSS · Real-Time Price · USD
0.820
-0.040 (-4.65%)
At close: Dec 20, 2024, 3:06 PM
0.810
-0.010 (-1.21%)
After-hours: Dec 20, 2024, 5:46 PM EST
DSS, Inc. Revenue
DSS, Inc. had revenue of $5.60M in the quarter ending September 30, 2024, with 33.88% growth. This brings the company's revenue in the last twelve months to $25.02M, down -17.43% year-over-year. In the year 2023, DSS, Inc. had annual revenue of $30.26M, down -36.04%.
Revenue (ttm)
$25.02M
Revenue Growth
-17.43%
P/S Ratio
0.23
Revenue / Employee
$263,358
Employees
95
Market Cap
5.85M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 30.26M | -17.05M | -36.04% |
| Dec 31, 2022 | 47.31M | 27.03M | 133.33% |
| Dec 31, 2021 | 20.28M | 4.91M | 31.95% |
| Dec 31, 2020 | 15.37M | -184.00K | -1.18% |
| Dec 31, 2019 | 15.55M | -2.97M | -16.01% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jowell Global | 160.01M |
| FGI Industries | 127.18M |
| E-Home Household Service Holdings | 50.69M |
| Golden Heaven Group | 25.55M |
| Inspire Veterinary Partners | 17.05M |
| Linkage Global | 8.50M |
| Energy Focus | 5.98M |
| SRM Entertainment | 4.59M |
DSS News
- 3 months ago - DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value - GlobeNewsWire
- 3 months ago - AmericaFirst Funds Trust Announces Changes to Board of Trustees - GlobeNewsWire
- 4 months ago - DSS, Inc. Names Jason Grady as Interim Chief Executive Officer - GlobeNewsWire
- 11 months ago - Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition." - GlobeNewsWire
- 1 year ago - DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market - GlobeNewsWire
- 1 year ago - DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan - GlobeNewsWire
- 1 year ago - Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years - GlobeNewsWire
- 1 year ago - DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder's Common Stock - GlobeNewsWire